title: Second Primary Cancers After Intensity-Modulated vs 3-Dimensional Conformal Radiation Therapy for Prostate Cancer.
authors.affiliation: Radiation Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.
authors.forename: Neige M Y
authors.initials: NM
authors.lastname: Journy
authors.affiliation: Radiation Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.
authors.forename: Lindsay M
authors.initials: LM
authors.lastname: Morton
authors.affiliation: Radiation Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.
authors.forename: Ruth A
authors.initials: RA
authors.lastname: Kleinerman
authors.affiliation: Department of Radiation Oncology, Abramson Cancer Center, Philadelphia, Pennsylvania3Center for Clinical Epidemiology and Biostatistics, Department of Biostatistics and Epidemiology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia4Leonard Davis Institute of Health Economics, University of Pennsylvania, Philadelphia.
authors.forename: Justin E
authors.initials: JE
authors.lastname: Bekelman
authors.affiliation: Radiation Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.
authors.forename: Amy
authors.initials: A
authors.lastname: Berrington de Gonzalez
mesh_terms: D000368:Aged; D000369:Aged, 80 and over; D006801:Humans; D007953:Leukemia, Radiation-Induced / Q000453:epidemiology / Q000209:etiology*; D008297:Male; D009190:Myelodysplastic Syndromes / Q000453:epidemiology / Q000209:etiology; D016609:Neoplasms, Second Primary / Q000453:epidemiology / Q000209:etiology*; D011471:Prostatic Neoplasms / Q000453:epidemiology / Q000532:radiotherapy*; D020266:Radiotherapy, Conformal / Q000009:adverse effects*; D012306:Risk